Open Access

Erratum to: Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study

  • Stijn A Peeters1, 2,
  • Lian Engelen1,
  • Jacqueline Buijs2,
  • Nish Chaturvedi3,
  • John H Fuller4,
  • Casper G Schalkwijk1,
  • Coen D Stehouwer1Email author and
  • EURODIAB Prospective Complications Study Group
Cardiovascular Diabetology201514:128

https://doi.org/10.1186/s12933-015-0290-4

Received: 17 September 2015

Accepted: 17 September 2015

Published: 28 September 2015

The original article was published in Cardiovascular Diabetology 2015 14:31

Erratum to: Cardiovascular Diabetology (2015) 14:31 DOI 10.1186/s12933-015-0195-2

After publication of the original article, it came to our attention that the samples used for the MMPs and TIMP-1 measurements were serum samples instead of plasma samples. Therefore,
  1. 1.

    Plasma levels of MMPs and TIMP-1 in the title, abstract, methods, results and discussion section should read serum levels; and

     
  2. 2.

    In the discussion section the sentence, “Possibly the serum measurement does not truly reflect the circulating concentration of MMPs and TIMPs compared to the plasma measurement” should be disregarded.

     

We apologize for any inconvenience.

Notes

Authors’ Affiliations

(1)
Department of Internal Medicine, Maastricht University Medical Centre
(2)
Department of Internal Medicine, Atrium Medical Centre
(3)
Institute of Cardiovascular Sciences, University College London
(4)
Department of Epidemiology and Public Health, University College London

Copyright

© Peeters et al. 2015

Advertisement